Related Experiment Video
Updated: Aug 5, 2026

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin-Based Pharmacotherapy for Weight Loss
Oqab Baniowdeh1, Ahmad Arar1, Yusuf Muslih1
1School of Medicine, University of Georgia, Tbilisi, Georgia.
Abstract:
Comparison of percentage total body weight loss (%TWL) between metabolic bariatric surgery and incretin-based pharmacotherapy in adults with type 2 diabetes mellitus. Forest plot showing pooled mean difference in percentage total body weight loss (%TWL) between treatment groups. Positive values favor metabolic bariatric surgery. Random-effects model with Hartung-Knapp adjustment was used.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Oral Hypoglycemic Agents: Biguanides and Glitazones
Dipeptidyl Peptidase 4 Inhibitors
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type II Diabetes II: Pathophysiology
